Chitosan Hydrogel Scaffold for Chondrocyte Phenotype Maintenance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for cartilage repair, particularly for large defects, face challenges in efficiently amplifying chondrocytes while maintaining their phenotype, as they tend to dedifferentiate during in vitro expansion, leading to the formation of non-functional fibrocartilage rather than hyaline cartilage, and existing 3D environments fail to provide optimal conditions for both proliferation and differentiation.
Innovation Solution
A method utilizing a physical hydrogel of chitosan or its derivative as a 3D scaffold for the amplification and re-differentiation of chondrocytes, allowing for homogeneous distribution and maintenance of the chondrocyte phenotype, enabling the synthesis of hyaline cartilage extracellular matrix without the need for cell trypsinization or scaffold changes, thereby facilitating direct implantation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If chondrocytes are amplified in vitro to increase cell number for implantation, then the quantity of cells is improved, but the chondrocyte phenotype is lost and they dedifferentiate into fibrocartilage
Solution Approach 1:
The patent transitions from traditional 2D monolayer culture to 3D scaffold-based culture. By embedding chondrocytes in a three-dimensional chitosan hydrogel scaffold, the cells maintain their chondrocyte phenotype during amplification. The 3D structure provides spatial constraints and mechanical cues that prevent dedifferentiation while allowing cell proliferation, thus resolving the contradiction between increasing cell quantity and maintaining phenotypic stability.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the culture environment by using chitosan hydrogel with specific porosity, mechanical properties, and biochemical composition. These parameter changes create an optimal microenvironment that supports both chondrocyte proliferation and phenotype maintenance, enabling cell amplification without dedifferentiation.
2Productivity
If chondrocytes are cultured in traditional 2D monolayer to amplify cell number, then productivity is improved, but manufacturing precision of cartilage tissue quality deteriorates
Solution Approach 1:
The invention moves from 2D monolayer culture to 3D scaffold-based culture, which maintains high productivity while dramatically improving manufacturing precision. The 3D chitosan hydrogel scaffold enables cells to produce hyaline cartilage with proper extracellular matrix composition (type II collagen and proteoglycans) rather than fibrocartilage, thus achieving both rapid amplification and high tissue quality.
Solution Approach 2:
The chitosan hydrogel scaffold acts as an intermediary between the cells and the culture medium, providing structural support, mechanical cues, and biochemical signals that guide chondrocyte behavior. This intermediary enables the cells to maintain their differentiation state while proliferating, producing high-quality hyaline cartilage tissue at high productivity.
3Productivity
If multiple passages are performed during amplification to obtain sufficient cell number, then productivity is improved, but the chondrocyte phenotype stability deteriorates and re-differentiation becomes more difficult
Solution Approach 1:
The patent performs preliminary action by embedding chondrocytes in the 3D chitosan hydrogel scaffold at an early stage, before multiple passages are conducted. This preliminary 3D structuring prevents phenotypic drift during subsequent passages, allowing the cells to maintain their chondrocyte characteristics even after extensive amplification, thus enabling both high productivity and phenotype stability.
4Manufacturing precision
If complex culture protocols with scaffold changes and trypsinization are used to maintain cell quality, then manufacturing precision is improved, but device complexity and loss of time increase
Solution Approach 1:
The patent merges the amplification and differentiation maintenance steps into a single continuous 3D culture process. Chondrocytes are embedded in the chitosan hydrogel scaffold once and remain there throughout the entire amplification period without requiring passage, trypsinization, or scaffold changes. This merging of steps maintains high tissue quality while dramatically simplifying the protocol and reducing time.
Solution Approach 2:
The continuous 3D culture system maintains useful action throughout the amplification process by keeping chondrocytes in their native-like environment. The cells continuously produce hyaline cartilage extracellular matrix without interruption or phenotypic drift, eliminating the need for complex intermediate steps while maintaining high manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for rapid and efficient multiplication and re-differentiation of chondrocytes within the same 3D structure, producing a cartilage gel ready for implantation within a shorter timeframe, ensuring high cell viability and maintaining the chondrocyte phenotype, thus providing a suitable solution for cartilage repair with improved tissue quality.
Implementation Method 1
a physical hydrogel of chitosan or a derivative of chitosan
Implementation Method 2
chondrocytes distributed in an extracellular matrix
Data Source
AI summary
The present invention concerns a method for obtaining an implantable cartilage gel for tissue repair of hyaline cartilage, comprising particles of chitosan hydrogel and cells that are capable of forming hyaline cartilage, said method comprising a step for amplification of primary cells in a three-dimensional structure comprising particles of physical hydrogel of chitosan or a chitosan derivative, then a step for re-differentiation and induction of the synthesis of extracellular matrix by said amplified cells, in the same three-dimensional structure, wherein said cells are primary articular chondrocytes and/or mesenchymal stem cells differentiated into chondrocytes. The present invention also concerns the cartilage gel obtained thereby, and its various uses for cartilage repair following a traumatic lesion or an osteoarticular disease such as osteoarthritis. The invention also concerns a three-dimensional matrix comprising particles of physical hydrogel of chitosan or of chitosan derivative, optionally supplemented with an anionic molecule such as hyaluronic acid or a derivative of hyaluronic acid or a complex of hyaluronic acid.